2026 NPPES data Interventional Cardiology Physician NPI 1720040488 MD
Verify on CMS →

MARK BARETTELLA, MD

Interventional Cardiology Physician in DAYTONA BEACH, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 426 beneficiaries · Interventional Cardiology Physician avg: 3K
Generic prescribing
84%
generic claims · 16% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · [object Object]
Industry payments
$275.56
4 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MARK BARETTELLA, MD is a Interventional Cardiology Physician ([object Object]) practicing in DAYTONA BEACH, Florida with a Medicare Part D prescribing footprint of 3K claims across 426 beneficiaries — 16% brand-name prescribing . Their CMS MIPS Final Score of 75/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $275.56 across 4 transactions are disclosed under CMS Open Payments (Sunshine Act).

What the federal data shows

MARK BARETTELLA, MD reported a CMS MIPS final score of 75/100 — below the 83.1 national average — and filed 3,484 Medicare Part D claims in 2023.

75/100
MIPS score · -8 vs avg
3K
Part D claims, 2023
84%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK BARETTELLA, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

75 15th percentile higher than 15% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MARK BARETTELLA, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MARK BARETTELLA, MD at a glance

Below national average

NPI registry status

Active

Issued 04/06/2006

NPI 1720040488

Primary specialty

Interventional Cardiology Physician

Niche

3,382 US NPIs in this specialty

Medicare Part D claims

3,484 17% vs specialty avg

2023 prescription claims

Specialty avg: 2,984

MIPS final score

75/100 8.099999999999994% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Florida

How Interventional Cardiology Physician compares to other specialties among Florida providers

Florida providers

Interventional Cardiology Physician share within Florida

1. Interventional Cardiology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Interventional Cardiology Physician share within Florida

Medicare quality performance — MIPS

MARK BARETTELLA, MD's 2023 MIPS final score plotted against the Interventional Cardiology Physician national average

Below national average
MIPS Final Score
75/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Interventional Cardiology Physician) — 75/100 vs national avg 83.1

0%100%National avg83%75%
MIPS final score (Interventional Cardiology Physician) — 75/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK BARETTELLA, MD is a Interventional Cardiology Physician provider practicing in DAYTONA BEACH, Florida, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1720040488. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARK BARETTELLA, MD appears in the CMS NPPES registry as a Interventional Cardiology Physician provider holding MD credentials at 311 N CLYDE MORRIS BLVD, DAYTONA BEACH, FL, 32114, with a listed phone of (386) 257-6644. NPI 1720040488 was issued on 04/06/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BARETTELLA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 3,484 prescription claims written by this provider, covering 426 Medicare beneficiaries and totaling roughly $650K in drug spend, split 16% brand-name and 84% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.

Interventional Cardiology Physician is a narrow specialty nationwide, with 3,382 enrolled providers across 53 states and an average of 2,984 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

311 N CLYDE MORRIS BLVD
DAYTONA BEACH, FL 32114

Provider Details

NPI 1720040488
Specialty Interventional Cardiology Physician
Credentials MD
Gender Male
NPI Issued 04/06/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
Avg: 83.1

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK BARETTELLA, MD. Source: openpaymentsdata.cms.gov.

Total received

$276

Largest payer

Abbott Laboratories

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to MARK BARETTELLA, MD. To verify MARK BARETTELLA, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

MARK BARETTELLA, MD — brand share 16.0%
Specialty average (est.)

16% brand-name claims vs 84% generic, on 3,484 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

3,484
Total Claims
$650K
Total Drug Cost
426
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
9,584
Total Day Supply
286,553
Brand vs Generic
16% brand / 84% generic
Brand Drug Cost
$561K
Generic Drug Cost
$90K

Patient Demographics

Average Patient Age
78.4 years
Avg HCC Risk Score
1.33
Gender Split
53% female / 47% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Amlodipine Besylate
264
Metoprolol Succinate
250
Eliquis
Apixaban
240
Losartan Potassium
224
Atorvastatin Calcium
204
Furosemide
176
Diltiazem 24hr Er (Cd)
Diltiazem Hcl
167
Rosuvastatin Calcium
165
Carvedilol
150
Hydrochlorothiazide
145

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Interventional Cardiology Physician Overview

How MARK BARETTELLA, MD fits within the Interventional Cardiology Physician landscape nationally.

3,382
Interventional Cardiology Physician Providers in US
53
States with Interventional Cardiology Physician
2,984
Avg Claims per Provider

MARK BARETTELLA, MD's 3,484 claims are above the specialty average of 2,984.

Nearby Interventional Cardiology Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as BARETTELLA.

Compare Interventional Cardiology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK BARETTELLA, MD's specialty?
MARK BARETTELLA, MD specializes in Interventional Cardiology Physician and practices in DAYTONA BEACH, Florida. Credentials: MD.
How much does MARK BARETTELLA, MD prescribe under Medicare Part D?
In 2023, MARK BARETTELLA, MD wrote 3,484 Medicare Part D claims totaling $650K in drug costs for 426 beneficiaries.
What is MARK BARETTELLA, MD's Medicare quality score?
MARK BARETTELLA, MD has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARK BARETTELLA, MD located?
MARK BARETTELLA, MD is located at 311 N CLYDE MORRIS BLVD, DAYTONA BEACH, FL, 32114. Phone: (386) 257-6644.
What is MARK BARETTELLA, MD's NPI number?
MARK BARETTELLA, MD's National Provider Identifier (NPI) is 1720040488, issued on 04/06/2006.
Does MARK BARETTELLA, MD prescribe more brand-name or generic drugs?
MARK BARETTELLA, MD's prescribing is 16% brand-name and 84% generic drugs by claim count, with $561K in brand drug costs.
How many Interventional Cardiology Physician providers are there in the US?
There are 3,382 Interventional Cardiology Physician providers across 53 states in the US. The average Interventional Cardiology Physician provider writes 2,984 Medicare Part D claims per year.
What drugs does MARK BARETTELLA, MD prescribe most often?
Based on 2023 Medicare Part D data, MARK BARETTELLA, MD's most frequently prescribed drugs include Amlodipine Besylate, Metoprolol Succinate, Eliquis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK BARETTELLA, MD accept Medicare?
MARK BARETTELLA, MD appears in CMS Medicare data with 3,484 Part D claims and 426 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK BARETTELLA, MD's credentials?
MARK BARETTELLA, MD's NPI is 1720040488 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology